Reuters logo
BRIEF-Vifor Pharma says CHMP recommends Veltassa for treatment of hyperkalaemia in EU
May 19, 2017 / 5:04 AM / 7 months ago

BRIEF-Vifor Pharma says CHMP recommends Veltassa for treatment of hyperkalaemia in EU

May 19 (Reuters) - VIFOR PHARMA LTD (IPO-VIFP.S):

    * CHMP RECOMMENDS VELTASSA FOR TREATMENT OF HYPERKALAEMIA IN EU

    * FINAL EU COMMISSION DECISION EXPECTED IN Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below